|
Accolade, Inc. (ACCD) DCF -Bewertung
US | Healthcare | Medical - Healthcare Information Services | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Accolade, Inc. (ACCD) Bundle
Unabhängig davon, ob Sie ein Anleger oder Analyst sind, ist dieser (ACCD) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Mit realen Daten von Accurade, Inc. geladen, können Sie Prognosen anpassen und die Auswirkungen sofort beobachten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 132.5 | 170.4 | 310.0 | 363.1 | 414.3 | 561.1 | 760.0 | 1,029.4 | 1,394.2 | 1,888.3 |
| Revenue Growth, % | 0 | 28.57 | 81.98 | 17.13 | 14.09 | 35.44 | 35.44 | 35.44 | 35.44 | 35.44 |
| EBITDA | -39.8 | -38.7 | -130.9 | -110.3 | -69.3 | -159.5 | -216.0 | -292.5 | -396.2 | -536.6 |
| EBITDA, % | -30.03 | -22.72 | -42.23 | -30.39 | -16.72 | -28.42 | -28.42 | -28.42 | -28.42 | -28.42 |
| Depreciation | 8.5 | 8.2 | 42.6 | 47.4 | 45.2 | 54.9 | 74.4 | 100.8 | 136.5 | 184.8 |
| Depreciation, % | 6.43 | 4.82 | 13.74 | 13.05 | 10.9 | 9.79 | 9.79 | 9.79 | 9.79 | 9.79 |
| EBIT | -48.3 | -46.9 | -173.5 | -157.7 | -114.5 | -214.4 | -290.4 | -393.3 | -532.7 | -721.5 |
| EBIT, % | -36.46 | -27.54 | -55.97 | -43.43 | -27.63 | -38.21 | -38.21 | -38.21 | -38.21 | -38.21 |
| Total Cash | 84.3 | 433.9 | 365.9 | 321.1 | 237.0 | 459.3 | 622.1 | 842.6 | 1,141.2 | 1,545.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 1.2 | 11.8 | 30.8 | 26.7 | 27.7 | 35.7 | 48.4 | 65.5 | 88.7 | 120.2 |
| Account Receivables, % | 0.89731 | 6.95 | 9.94 | 7.35 | 6.69 | 6.36 | 6.36 | 6.36 | 6.36 | 6.36 |
| Inventories | 1.6 | 2.3 | 3.0 | 4.0 | .0 | 5.2 | 7.1 | 9.6 | 13.0 | 17.7 |
| Inventories, % | 1.24 | 1.35 | 0.97251 | 1.11 | 0 | 0.93498 | 0.93498 | 0.93498 | 0.93498 | 0.93498 |
| Accounts Payable | 5.3 | 7.4 | 7.8 | 10.2 | 13.7 | 19.0 | 25.8 | 34.9 | 47.3 | 64.1 |
| Accounts Payable, % | 3.98 | 4.34 | 2.53 | 2.8 | 3.32 | 3.39 | 3.39 | 3.39 | 3.39 | 3.39 |
| Capital Expenditure | -3.3 | -2.4 | -3.6 | -7.2 | -12.5 | -11.3 | -15.3 | -20.7 | -28.1 | -38.0 |
| Capital Expenditure, % | -2.5 | -1.39 | -1.17 | -1.99 | -3.01 | -2.01 | -2.01 | -2.01 | -2.01 | -2.01 |
| Tax Rate, % | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 | -1.25 |
| EBITAT | -48.4 | -46.9 | -165.9 | -156.5 | -115.9 | -212.2 | -287.4 | -389.2 | -527.2 | -714.0 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -40.8 | -50.3 | -146.2 | -110.9 | -76.6 | -176.5 | -236.0 | -319.7 | -433.0 | -586.5 |
| WACC, % | 11.13 | 11.13 | 11.08 | 11.12 | 11.13 | 11.12 | 11.12 | 11.12 | 11.12 | 11.12 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,213.3 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -598 | |||||||||
| Terminal Value | -6,560 | |||||||||
| Present Terminal Value | -3,873 | |||||||||
| Enterprise Value | -5,086 | |||||||||
| Net Debt | 56 | |||||||||
| Equity Value | -5,142 | |||||||||
| Diluted Shares Outstanding, MM | 75 | |||||||||
| Equity Value Per Share | -68.64 |
What You Will Get
- Real ACCD Financial Data: Pre-filled with Accolade, Inc.'s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See Accolade, Inc.'s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Comprehensive ACCD Data: Pre-populated with Accolade’s past performance metrics and future growth estimates.
- Customizable Assumptions: Modify projections for revenue growth, profit margins, discount rates, tax implications, and capital investments.
- Interactive Valuation Framework: Real-time updates to Net Present Value (NPV) and intrinsic value based on user inputs.
- Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate diverse valuation possibilities.
- Intuitive User Interface: Designed to be straightforward and accessible for both seasoned professionals and newcomers.
How It Works
- 1. Access the Template: Download and open the Excel file containing Accolade, Inc.'s (ACCD) preloaded financial data.
- 2. Adjust Key Inputs: Modify essential parameters such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically calculates the intrinsic value and NPV based on your inputs.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation possibilities.
- 5. Present with Assurance: Share professional valuation findings to enhance your decision-making process.
Why Choose This Calculator for Accolade, Inc. (ACCD)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned users.
- Customizable Inputs: Modify assumptions effortlessly to tailor your analysis.
- Real-Time Valuation: Observe immediate updates to Accolade’s valuation as you change inputs.
- Preloaded Data: Comes with Accolade’s actual financial metrics for streamlined analysis.
- Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.
Who Should Use This Product?
- Investors: Accurately assess Accolade, Inc.'s (ACCD) fair value prior to making investment choices.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis.
- Consultants: Efficiently tailor the template for valuation reports tailored to clients.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading companies.
- Educators: Implement it as a teaching resource to illustrate valuation methodologies.
What the Template Contains
- Pre-Filled Data: Includes Accolade, Inc.'s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Accolade, Inc.'s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.